SIGA Technologies Stock Price, News & Analysis (OTCMKTS:SIGA)

$6.06 +0.19 (+3.24 %)
(As of 03/21/2018 02:44 AM ET)
Previous Close$5.87
Today's Range$6.00 - $6.40
52-Week Range$2.85 - $6.78
Volume97,340 shs
Average Volume44,912 shs
Market Capitalization$455.70 million
P/E Ratio-11.43
Dividend YieldN/A

About SIGA Technologies (OTCMKTS:SIGA)

SIGA Technologies logoSIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.

Receive SIGA News and Ratings via Email

Sign-up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry DRUGS


Debt-to-Equity Ratio-0.22%
Current Ratio5.49%
Quick Ratio5.05%


Trailing P/E Ratio-11.4337465330843
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.26 million
Price / Sales39.00
Cash FlowN/A
Price / CashN/A
Book Value($4.09) per share
Price / Book-1.48


Trailing EPS($0.53)
Net Income$-36,230,000.00
Net Margins-295.39%
Return on EquityN/A
Return on Assets-23.75%


Outstanding Shares78,910,000

SIGA Technologies (OTCMKTS:SIGA) Frequently Asked Questions

What is SIGA Technologies' stock symbol?

SIGA Technologies trades on the OTCMKTS under the ticker symbol "SIGA."

How were SIGA Technologies' earnings last quarter?

SIGA Technologies, Inc. (OTCMKTS:SIGA) posted its quarterly earnings results on Thursday, May, 1st. The biotechnology company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by $0.28. The biotechnology company had revenue of $0.55 million for the quarter, compared to analysts' expectations of $26.50 million. View SIGA Technologies' Earnings History.

Who are some of SIGA Technologies' key competitors?

Who are SIGA Technologies' key executives?

SIGA Technologies' management team includes the folowing people:

  • Eric A. Rose M.D., Executive Chairman of the Board (Age 66)
  • Phillip Louis Gomez III, Chief Executive Officer, Director (Age 49)
  • Daniel J. Luckshire, Chief Financial Officer, Executive Vice President, Secretary (Age 44)
  • Dennis E. Hruby Ph.D., Chief Scientific Officer, Vice President (Age 63)
  • James J. Antal CPA, Independent Director (Age 65)
  • Michael Jonathan Bayer, Independent Director (Age 66)
  • Thomas E. Constance, Independent Director (Age 81)
  • Jeffrey B. Kindler, Independent Director (Age 61)
  • Joseph W. Marshall III, Independent Director (Age 64)

Has SIGA Technologies been receiving favorable news coverage?

Media headlines about SIGA stock have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. SIGA Technologies earned a coverage optimism score of 0.19 on Accern's scale. They also gave press coverage about the biotechnology company an impact score of 46.87 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of SIGA Technologies?

Shares of SIGA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SIGA Technologies' stock price today?

One share of SIGA stock can currently be purchased for approximately $6.06.

How big of a company is SIGA Technologies?

SIGA Technologies has a market capitalization of $455.70 million and generates $12.26 million in revenue each year. The biotechnology company earns $-36,230,000.00 in net income (profit) each year or ($0.53) on an earnings per share basis. SIGA Technologies employs 37 workers across the globe.

How can I contact SIGA Technologies?

SIGA Technologies' mailing address is 27 EAST 62ND STREET, NEW YORK NY, 10065. The biotechnology company can be reached via phone at 212-672-9100 or via email at [email protected]

MarketBeat Community Rating for SIGA Technologies (SIGA)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  125
MarketBeat's community ratings are surveys of what our community members think about SIGA Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

SIGA Technologies (OTCMKTS:SIGA) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


SIGA Technologies (OTCMKTS:SIGA) Earnings History and Estimates Chart

Earnings by Quarter for SIGA Technologies (OTCMKTS:SIGA)

SIGA Technologies (OTCMKTS SIGA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017Q2 2017($0.10)$4.27 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.11)$5.20 millionViewN/AView Earnings Details
3/7/2017Q4 2016($0.15)$7.16 millionViewN/AView Earnings Details
11/2/2016Q3 2016($0.17)$4.66 millionViewN/AView Earnings Details
8/8/2016Q2 2016($0.18)$1.90 millionViewN/AView Earnings Details
5/4/2016Q1 2016($0.19)$1.27 millionViewN/AView Earnings Details
3/4/2016Q4 2015($0.34)$4.19 millionViewN/AView Earnings Details
10/27/2015Q3 2015($0.06)$1.33 millionViewN/AView Earnings Details
8/4/2015Q2 2015($0.08)$1.47 millionViewN/AView Earnings Details
5/6/2015Q1 2015($0.11)$1.19 millionViewN/AView Earnings Details
3/6/2015Q4 2014($0.33)$0.84 millionViewN/AView Earnings Details
11/4/2014Q3 2014($1.20)$1.10 millionViewN/AView Earnings Details
7/31/2014Q2 2014($0.06)$0.65 millionViewN/AView Earnings Details
5/1/2014Q1$0.22($0.06)$26.50 million$0.55 millionViewListenView Earnings Details
3/10/2014Q413($0.08)$2.50 million$0.90 millionViewN/AView Earnings Details
11/6/2013Q313($0.09)$69.00 million$2.29 millionViewN/AView Earnings Details
8/5/2013Q2 2013($0.09)($0.10)$2.75 million$0.97 millionViewN/AView Earnings Details
5/15/2013Q1 2013($0.09)($0.09)$2.75 million$1.38 millionViewN/AView Earnings Details
3/6/2013Q4 2012($0.07)($0.06)$5.00 million$2.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.11($0.06)$3.60 million$2.30 millionViewN/AView Earnings Details
8/6/2012Q2 2012($0.08)($0.12)ViewN/AView Earnings Details
5/7/2012Q1 2012($0.12)($0.08)ViewN/AView Earnings Details
3/1/2012Q4 2011$0.25($0.10)ViewN/AView Earnings Details
8/1/2011Q2 2011($0.07)($0.20)ViewN/AView Earnings Details
5/5/2011Q1 2011($0.06)($0.09)ViewN/AView Earnings Details
11/2/2010Q3 2010($0.08)($0.10)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.07)($0.10)ViewN/AView Earnings Details
5/4/2010Q1 2010($0.09)($0.10)ViewN/AView Earnings Details
3/10/2010Q4 2009($0.04)$0.02ViewN/AView Earnings Details
11/9/2009Q3 2009($0.04)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.05)($0.28)ViewN/AView Earnings Details
5/11/2009Q1 2009($0.19)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.09)ViewN/AView Earnings Details
8/12/2008Q2 2008($0.09)($0.09)ViewN/AView Earnings Details
5/12/2008Q1 2008($0.03)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


SIGA Technologies (OTCMKTS:SIGA) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for SIGA Technologies (OTCMKTS:SIGA)

No dividend announcements for this company have been tracked by

Insider Trades

SIGA Technologies (OTCMKTS SIGA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.71%
Institutional Ownership Percentage: 6.66%
Insider Trades by Quarter for SIGA Technologies (OTCMKTS:SIGA)

SIGA Technologies (OTCMKTS SIGA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2014& Forbes Holdings I MacandrewsDirectorBuy199,727$1.50$299,590.50View SEC Filing  
9/26/2014Bruce SlovinDirectorSell25,000$1.35$33,750.00View SEC Filing  
9/24/2014& Forbes Holdings I MacandrewsDirectorBuy204,157$1.34$273,570.38View SEC Filing  
9/23/2014& Forbes Holdings I MacandrewsDirectorBuy151,158$1.33$201,040.14View SEC Filing  
9/17/2013Michael BayerDirectorBuy15,000$3.58$53,700.0015,000View SEC Filing  
9/13/2013Michael BayerDirectorSell15,000$3.55$53,250.00View SEC Filing  
5/30/2013Bruce SlovinDirectorSell15,000$3.83$57,450.00View SEC Filing  
5/24/2013Joseph W Marshall IIIDirectorBuy7,000$3.59$25,130.00View SEC Filing  
(Data available from 1/1/2013 forward)


SIGA Technologies (OTCMKTS SIGA) News Headlines

SIGA Technologies Announces Relisting on NasdaqSIGA Technologies Announces Relisting on Nasdaq - March 20 at 10:29 AM
Oregon-developed biological warfare drug treatment nears FDA finish lineOregon-developed biological warfare drug treatment nears FDA finish line - March 1 at 4:00 PM
Emerging Developments: New Research on Siga Technologies and Tropicana Entertainment - A Look Ahead into 2018Emerging Developments: New Research on Siga Technologies and Tropicana Entertainment - A Look Ahead into 2018 - February 27 at 10:35 AM
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat SmallpoxSIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox - February 7 at 8:31 AM
Contrasting Trillium Therapeutics (TRIL) & SIGA Technologies (SIGA)Contrasting Trillium Therapeutics (TRIL) & SIGA Technologies (SIGA) - January 9 at 7:08 PM
Trillium Therapeutics (TRIL) & SIGA Technologies (SIGA) Head-To-Head AnalysisTrillium Therapeutics (TRIL) & SIGA Technologies (SIGA) Head-To-Head Analysis - January 6 at 11:36 PM
Comparing SIGA Technologies (SIGA) & VBI Vaccines (VBIV)Comparing SIGA Technologies (SIGA) & VBI Vaccines (VBIV) - January 3 at 3:12 AM
SIGA Technologies (SIGA) and Affymax (AFFY) Head to Head ContrastSIGA Technologies (SIGA) and Affymax (AFFY) Head to Head Contrast - December 25 at 1:34 AM
Contrasting Windtree Therapeutics (WINT) and SIGA Technologies (SIGA)Contrasting Windtree Therapeutics (WINT) and SIGA Technologies (SIGA) - December 22 at 10:10 AM
SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat SmallpoxSIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox - December 11 at 9:16 AM
SIGA Technologies (SIGA) Downgraded to "Sell" at ValuEngineSIGA Technologies (SIGA) Downgraded to "Sell" at ValuEngine - December 5 at 10:12 PM
Head-To-Head Review: Mateon Therapeutics (MATN) and SIGA Technologies (SIGA)Head-To-Head Review: Mateon Therapeutics (MATN) and SIGA Technologies (SIGA) - November 30 at 9:34 PM
SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 - November 29 at 8:34 AM

SEC Filings

SIGA Technologies (OTCMKTS:SIGA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


SIGA Technologies (OTCMKTS:SIGA) Income Statement, Balance Sheet and Cash Flow Statement


SIGA Technologies (OTCMKTS SIGA) Stock Chart for Wednesday, March, 21, 2018

Loading chart…

This page was last updated on 3/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.